Ohio has hit the brakes on new rehab facilities. In 2026, the state froze applications for addiction treatment centers in Southern Ohio. It’s a direct response to fraud concerns. Here’s the thing: some bad actors have been more interested in profit than recovery. And it’s hurting people who need help.

At Recovery Institute of Ohio, we see the damage these shady operations cause. Patients get substandard care. Families drain savings. Trust in the system erodes. That’s why this freeze matters.

Let’s break down what happened, why it happened, and what it means for you or your loved one.

What Exactly Did Ohio Do?

The freeze targets new rehab facility applications in Southern Ohio. That includes places like Columbus, Cincinnati, and rural counties hit hard by the opioid crisis. The Ohio Department of Behavioral Health (ODBH) announced the pause in early June 2026.

According to a statement from the Ohio House of Representatives, the goal is to “enhance oversight and accountability measures” after reports of fraud. Some facilities were billing for treatments they never provided. Others operated without proper licenses. It’s a mess.

“We’re not trying to stop recovery. We’re trying to stop fraud,” said an ODBH spokesperson.

This freeze isn’t forever. It’s a pause while the state reviews its regulations. New facilities will have to prove they meet higher standards before opening. Existing ones? They’re being scrutinized too.

Why This Fraud Happens

Addiction treatment is big business in Ohio. The state has poured millions into recovery programs, including opioid settlement funds. Unfortunately, where there’s money, there’s temptation.

Some facilities hired unqualified staff, falsified patient records, or ran insurance scams. Patients stayed for weeks without real therapy. Then they relapsed almost immediately. It’s heartbreaking.

We’ve written before about Ohio Bill Targets Troubled Rehab Facilities. That legislation aims to crack down on exactly these practices. The freeze is another tool in that effort.

What This Freeze Means for Treatment Seekers

If you’re looking for rehab in Ohio right now, don’t panic. The freeze only applies to new facilities. Existing centers — including those with good track records — are still operating. But you need to be careful.

Here’s what to look for:

• Licensing: Ohio requires rehab centers to be certified by the state. Check with ODBH before enrolling.
• Accreditation: Look for accreditation from groups like CARF or The Joint Commission.
• Transparency: A reputable facility will answer all your questions about staff, treatment plans, and costs.
• Personalized care: Avoid one-size-fits-all programs. Recovery is different for everyone.

At Recovery Institute of Ohio, we’re fully licensed and accredited. We believe in honest, compassionate care. And we’re not going anywhere.

Ohio’s Broader Fight Against Rehab Fraud

This freeze is part of a larger trend. In 2026, Ohio lawmakers introduced several bills to clean up the industry. For example, Your Guide to Ohio’s 2026 Opioid Settlement Grant Funding for Treatment shows how the state is redirecting money to ethical providers.

Meanwhile, new rules for recovery residences aim to ensure safe housing. All these efforts work together to protect patients.

The message is clear: Ohio wants treatment, not exploitation. And families deserve to know where to get real help.

How to Choose a Rehab Center in This Climate

So how do you find a place you can trust? Start with research. Look for facilities that have been around for years, not months. Check online reviews — but take them with a grain of salt. Some fake reviews exist.

Call the facility. Ask tough questions: Who provides therapy? What credentials do they have? Can you tour the center? If they’re evasive, walk away.

Also, talk to your doctor or a local addiction specialist. They often know which centers have good reputations. And they can help you navigate insurance and payment options.

Remember: recovery is possible. But only if you find the right support.

Conclusion: Help Is Still Here

The freeze on rehab facilities is a good thing. It means Ohio is serious about quality. But it also means you need to be proactive. Don’t settle for less than excellent care.

If you’re struggling with addiction, reach out. You’re not alone. Recovery is possible, and it starts with a single call.

Contact Recovery Institute of Ohio today at (888) 705-0886 or visit our website. We’re here to help — no games, no fraud, just real healing.

 

Ohio opioid overdose deaths have fallen by nearly 50% since 2023. That’s not just a statistic. It’s a sign of hope. For families in Columbus, Cleveland, and Cincinnati, it means fewer empty chairs at the dinner table. For our communities, it’s proof that the relentless work is paying off. But what does this dramatic drop actually mean? Let’s break it down.

A Statewide Shift: The Numbers Tell a Story of Progress

The headline is staggering. Opioid overdose deaths in Ohio have plummeted by close to 50% since 2023. Think about that for a second. That’s potentially thousands of lives saved across our state. It’s a decline that, as Cleveland.com noted, was “even steeper” than the national trend in 2024. This isn’t a fluke. We’re seeing a sustained, coordinated effort finally yielding tangible results.

Here at the Recovery Institute of Ohio, we’ve felt this shift. The calls for help are changing. There’s more urgency, but there’s also more hope. People are hearing that recovery is possible because they’re seeing it in their own neighborhoods. They’re witnessing fewer tragedies and more success stories. This data validates what many on the front lines have been feeling—a genuine turning point.

Local Victories: Hamilton County Leads the Way

Zoom in on Cincinnati and Hamilton County, and the picture gets even more compelling. Overdose deaths there have hit their lowest point in over a decade. A decade. The county government announced this marks the fourth consecutive year of declining deaths. That’s a real trend. It shows what’s possible when local resources, law enforcement, healthcare providers, and community organizations align with a single mission.

What does this mean for families in Cincinnati? It means the strategies being deployed—from widespread naloxone distribution to connecting people with treatment faster—are working. It’s a model other Ohio counties are watching closely. The success in Hamilton County proves that targeted, persistent community action can save lives. It’s a powerful example for Cleveland, Dayton, and Akron to follow.

What’s Driving the Decline? It’s Not One Magic Bullet

So where does this progress come from? Here’s the thing. There isn’t a single hero in this story. It’s a symphony of efforts, each playing a critical part. First, the expansion of the overdose-reversal drug naloxone has been absolutely vital. It’s in the hands of more first responders, community groups, and even families than ever before. That means more second chances.

We’ve also seen a significant increase in access to treatment. This includes Medication-Assisted Treatment (MAT), which we know is one of the most effective tools we have. In our treatment programs, we see firsthand how MAT, combined with counseling and support, provides the stability needed for long-term recovery. Ohio’s substantial federal SOS (State Opioid Response) funding has directly fueled this expansion, putting more resources into communities that desperately need them.

The Role of Harm Reduction and Community Action

Beyond medical treatment, a broader cultural shift towards harm reduction is making a difference. This means meeting people where they are. Syringe service programs, fentanyl test strip distribution, and “warm handoff” programs that connect overdose survivors directly to treatment are all part of the equation. These strategies acknowledge the complexity of addiction. They work to reduce risk while building trust.

Community initiatives have been game-changers. As we discussed in our article on Targeted Interventions in Cincinnati, focusing efforts on high-risk areas with tailored outreach can have an outsized impact. It’s about bringing resources directly to the neighborhoods and people who need them most, breaking down barriers of transportation and stigma.

What This Means for Ohio Families Seeking Help Today

If you or someone you love is struggling, this news should be a beacon. It means the system is getting better at catching people. Effective help is more available than it was just a few years ago. But the work is far from over. The decline in deaths is monumental, but every single overdose death is still a profound loss. Our goal must be zero.

What can you do right now? Know the signs of an overdose. Have naloxone accessible. Most importantly, know that treatment works. Recovery is not a distant dream; it’s a reality for thousands of Ohioans. The pathways to get there—through detox, residential treatment, outpatient programs, and sober living—are more navigable thanks to the infrastructure built during this fight.

Navigating the Road Ahead: Challenges and Opportunities

The progress is real, but it’s fragile. The drug supply remains dangerous and unpredictable. Funding must be sustained. And we must continue to combat the stigma that still prevents people from asking for help. We understand how hard that first step can be.

Legal and policy landscapes also play a role. For instance, recent rulings like the one where the Ohio Supreme Court Blocks Public Nuisance Claims Against National Pharmacies show the complex interplay between litigation and public health strategy.

Similarly, pharmacy practices directly affect access. Discussions around dispensing, as highlighted when Walgreens Takes On DEA Over New Opioid Dispensing Policies, remind us that every point in the chain—from manufacturer to patient—matters in preventing misuse while ensuring legitimate pain management and treatment access.

Your Next Step: How Recovery Institute of Ohio Can Help

Here’s the most important part. This data represents a collective victory, but your personal journey starts with a single step. Maybe you’re in Toledo feeling hopeless. Perhaps you’re a parent in Springfield watching your child struggle. The message is clear: help is here, and it works. You are not alone.

At Recovery Institute of Ohio, we walk this path with you. We offer evidence-based treatment tailored to your needs, connecting you with a community of support that understands. The nearly 50% drop in deaths is a testament to what’s possible when we fight this disease with compassion and science. Now, let’s write the next chapter of your story.

Recovery is possible. It starts with reaching out. If you’re ready to begin, call our team today. Let’s talk about your path forward, right here in Ohio.

Ohio prisons are being overrun with K2 and fentanyl. It’s a crisis behind bars that’s claiming lives and overwhelming a system already stretched thin. The numbers are staggering: overdoses, deaths, and contraband flowing in despite heightened security. But what does this mean for families in Columbus, Cleveland, or Cincinnati with a loved one inside?

Let’s break this down. The Marshall Project recently published a deep investigation into how deadly synthetic drugs are smuggled into Ohio prisons. Smugglers promise big money, but they leave a stream of overdose victims. We see the fallout every day at Recovery Institute of Ohio—incarcerated individuals who cycle through addiction without access to real treatment.

The Scope of the Crisis: K2 and Fentanyl Flooding Prisons

Synthetic drugs like K2—often called “spice” or “synthetic marijuana”—are easy to manufacture and even easier to smuggle. They’re sprayed onto plant material and can be soaked into paper, making them nearly invisible to scanners. Fentanyl, potent enough to kill in microscopic amounts, is often mixed in. The result? A wave of overdoses inside Ohio’s correctional facilities.

According to the Marshall Project report, smugglers use drones, corrupt staff, and even the mail to get drugs past security. Once inside, the drugs spread fast. Inmates describe a market where K2 is traded like currency. Guards find themselves outnumbered and outmaneuvered. The human cost is steep: families receive calls that their loved one has overdosed—sometimes fatally.

How Did We Get Here? Policy Gaps and Funding Challenges

Ohio has tried to respond. The Attorney General’s office, under Dave Yost, has a grant program to combat inmate addiction that continues in 2026. But the problem persists. Why? Because the flow of contraband is relentless. And treatment inside prisons is inconsistent at best. Many facilities lack Medication-Assisted Treatment (MAT) for opioid addiction, leaving inmates without the tools to recover. What does this actually mean? It means people are released into communities like Dayton or Akron still in the grip of addiction, often with a tolerance lowered by forced abstinence, making them more vulnerable to overdose.

As we discussed in our article on The Rise of Fentanyl in Ohio: What Families Should Know, the danger of fentanyl extends beyond prison walls. But inside, it’s even more concentrated.

“Smugglers offer promises of big money, but leave a stream of overdose victims.” — The Marshall Project, March 2026

What Experts and Officials Are Saying

Ohio Attorney General Dave Yost has highlighted the need for continued grant funding to combat inmate addiction. The Recovery Ohio Law Enforcement Fund, for example, recommends grants for programs that target drug trafficking in prisons. But critics argue that without expanding treatment—not just interdiction—the cycle will continue.

We see this firsthand in our treatment programs at Recovery Institute of Ohio. Inmates who do get treatment often relapse shortly after release because the support system isn’t there. There’s a disconnect between prison-based programs and community-based recovery. And it’s costing lives.

What This Means for Ohio Families and Communities

If you have a loved one incarcerated in Ohio, you know the fear. You worry about their health, their safety. The reality is that prisons in places like Lucas County, Franklin County, and Cuyahoga County are grappling with this epidemic. The overdoses don’t stay behind bars—they ripple out to families, emergency rooms, and neighborhoods.

There is some good news: Drop in opioid overdose deaths nears 50% since 2023, according to a Stateline report. But that decline may not be reflected inside prisons, where the use of unpredictable synthetic drugs like K2 and fentanyl is spiking. The mix of these two drugs is a recipe for disaster. One hit of K2 could contain a lethal dose of fentanyl.

Recovery Options for Incarcerated Individuals and Families

So what can you do? First, know that there are pathways to recovery, even for those inside. The Ohio Department of Mental Health and Addiction Services (OhioMHAS) supports reentry programs that connect inmates to treatment upon release. Programs like the Recovery Ohio Law Enforcement Fund are providing grants to improve addiction care in correctional settings. And at Recovery Institute of Ohio, we offer specialized support for individuals returning from prison, including counseling and MAT.

For families, education is key. Learn the signs of K2 and fentanyl use. Talk to your loved one about the risks. And don’t hesitate to seek help for yourself—addiction is a family disease. As we covered in Burnout Among Frontline Workers in Ohio: Secondary Trauma, Fatigue, and What’s Working, the stress of supporting an incarcerated loved one can be overwhelming. You’re not alone.

A Path Forward: Treatment and Policy Change

The crisis in Ohio prisons isn’t going away overnight. But with continued funding, better policies, and a focus on treatment over punishment, change is possible. Ohio’s drug court expansion—which we explored in Drug Court Expansion In Ohio: A Shift from Jail To Treatment—is one example of a shift away from incarceration and toward recovery. We need that same mindset inside prisons.

Recovery is possible, and it starts with reaching out. If you or someone you love is struggling with addiction—whether behind bars or at home—our team at Recovery Institute of Ohio is here to help. We offer compassionate, evidence-based treatment tailored to your needs. Don’t wait. Call us today at (888) 705-0886 or visit our website to learn more.

A new Ohio rehab facility bill could finally force the state to shut down residential treatment centers that repeatedly fail to meet basic safety standards. House Bill 811, introduced in April 2026, aims to take discretion away from the Ohio Department of Behavioral Health when a facility shows a pattern of non-compliance. For families in Columbus, Cleveland, Cincinnati, and across Ohio, this legislation promises greater accountability — and peace of mind.

Here’s the thing: too many Ohioans have been hurt by facilities that should have been shut down long ago. At Recovery Institute of Ohio, we see the aftermath — people who suffered neglect, abuse, or unsafe conditions while trying to get sober. That’s not how recovery should work.

 

What House Bill 811 Actually Does

The bill, sponsored by state representatives Crystal Lett and others, would require the Ohio Department of Behavioral Health to revoke the license of any residential treatment facility that accumulates multiple serious violations within a set timeframe. Right now, the department has broad discretion — meaning they can choose to keep a facility open even after major infractions. HB 811 takes that choice away.

“The proposal comes just months after The Marshall Project – Cleveland exposed violence at a residential youth facility northeast of Columbus,” reported The Land. That facility, Mohican Young Star Academy, was the subject of a damning investigation revealing physical abuse, sexual misconduct, and systemic failures. The exposé sparked outrage — and apparently, legislative action.

But it’s not just about that one place. In Cleveland, another facility — Oriana House — made headlines in April 2026 when it faced criminal charges for mold violations at its Cuyahoga County Diversion Center. Mike Mason of Cleveland 19 News reported that the facility failed to clean up mold found throughout the building, putting vulnerable people at risk.

These aren’t isolated incidents. They’re symptoms of a system that’s too often prioritized profit over people.

How We Got Here — A Brief History of Ohio’s Treatment Facility Crisis

Ohio has long struggled with oversight of residential treatment facilities. When the opioid epidemic surged, the state licensed dozens of new facilities in the 2010s — many of which lacked proper regulation. Stories of abuse, neglect, and unsafe conditions piled up.

In our experience at Recovery Institute of Ohio, we’ve seen clients come to us after being discharged from facilities that couldn’t provide basic care. They’ve shared stories of understaffed centers, unsanitary conditions, and even physical harm. It’s heartbreaking — and that’s exactly why we support legislation like HB 811.

Governor DeWine has also taken steps to address the crisis, announcing nearly $5 million to combat drug trafficking and prevent substance use disorder. But that doesn’t fix the problem of bad actors operating within the system. The bill is part of a broader push for accountability, following similar measures in other states.

What This Means for Ohio Families

For families searching for a safe detox or residential program, HB 811 is a game-changer. It means that facilities with a track record of non-compliance can’t keep their doors open — and the state can’t look the other way.

But here’s the catch: enforcement relies on reporting. The Marshall Project’s investigation was dogged journalism, but not every bad facility gets that kind of scrutiny. Families need to do their own homework too. Ask questions: Is the facility licensed? Have there been any complaints? What does the state inspection report say?

We also see this as a chance to shift the conversation. As we discussed in our article on Drug Court Expansion In Ohio: A Shift from Jail To Treatment, the state is increasingly recognizing that treatment should be a health issue, not a criminal one. But for that to work, treatment has to be safe and effective.

What Happens Next? The Bill’s Chances and Timeline

HB 811 is currently in committee. It has bipartisan support, but it also faces pushback from facility operators who argue it could lead to closures that reduce access to care. That’s a legitimate concern — but access to bad care isn’t access at all.

The Ohio Department of Behavioral Health hasn’t taken a formal position, but sources suggest they’re wary of losing flexibility. Still, the public pressure from news coverage and advocacy groups is mounting.

If passed, the bill would take effect 90 days after being signed into law. That means we could see changes as early as late 2026. But don’t wait for the law to change to start asking the tough questions.

How to Find a Safe, Compliant Rehab Facility in Ohio

So what should you look for? First, make sure the facility is licensed by the Ohio Department of Behavioral Health. You can check their online database for any violations. Second, ask about staff-to-patient ratios, credentials, and oversight. A good facility will be transparent.

At Recovery Institute of Ohio, we believe in full transparency. Our programs in Columbus and throughout the state are designed to meet the highest standards of care. We offer medical detox, residential treatment, and outpatient services — all in a safe, supportive environment. For more on treatment approaches, check out our guide on What Is Medication-Assisted Treatment (MAT)?

Also, stay informed. The Opioid Treatment Program Rule Changes In Ohio are another important piece of the puzzle. Together, these developments signal a shift toward higher standards across the board.

Your Recovery, Your Safety — We’re Here to Help

Legislation like HB 811 is a step in the right direction, but it’s not the whole answer. Real change happens when people — families, advocates, and providers — demand better. And if you’re reading this because you or someone you love needs help, don’t wait for the law to fix everything.

Recovery is possible, and it starts with reaching out. At Recovery Institute of Ohio, we’ve helped thousands of Ohioans find their path to sobriety in a safe, compassionate setting. Don’t trust your life to a facility that might be the next headline.

Call us today at (888) 705-0886 or visit recoveryinstituteofohio.com to learn more. Your safety is our priority — always.

Just as Ohio was seeing a glimmer of hope—overdose deaths dropping nearly 50% since 2023, according to recent reports—a new threat has emerged. Medetomidine, a powerful veterinary sedative never meant for human use, is showing up in the illegal fentanyl supply. The CDC issued a health advisory on April 2, 2026, warning that medetomidine in Ohio’s fentanyl is increasing the risk of overdose and causing a severe withdrawal syndrome that can land people in the ICU.

Here’s the thing: this isn’t some far-off problem. It’s here, in our communities—Columbus, Cleveland, Cincinnati, Dayton, Akron. And it’s making an already dangerous drug supply even more unpredictable.

What Is Medetomidine—and Why Should Ohioans Care?

Medetomidine, sometimes called ‘rhino tranq,’ ‘mede,’ or ‘dex’ on the street, is a sedative approved only for dogs. Its close cousin, dexmedetomidine, is used in hospitals for procedural sedation in humans. But what’s being found in fentanyl isn’t pharmaceutical grade. According to the CDC, lab tests show racemic mixtures of medetomidine isomers without the preservatives found in medical or veterinary products. That means it’s being cooked up in clandestine labs, not diverted from a vet’s office.

Why does that matter? Because medetomidine is potent. It causes profound sedation, dangerously slow heart rate, and low blood pressure. And when someone uses it regularly and stops, the withdrawal is brutal—hypertension, anxiety, nausea, vomiting, and fluctuating alertness. Some people need emergency or intensive care just to get through it.

At Recovery Institute of Ohio, we see firsthand how the drug supply is changing. As we discussed in our article on The Rise of Fentanyl in Ohio: What Families Should Know, fentanyl has already reshaped the overdose crisis. Medetomidine adds a new layer of danger.

The CDC’s Warning: What the Data Shows

The CDC’s Health Alert Network advisory, released April 2, 2026, didn’t mince words. It says medetomidine is being “increasingly detected in law enforcement drug seizures, drug product and paraphernalia samples, and in wastewater samples.” The highest concentrations are showing up in the Northeast, but Ohio—with its major transportation corridors and urban centers—is right in the path.

Here’s what’s particularly scary: because fentanyl is involved in most overdoses where medetomidine is found, naloxone (Narcan) should still be given to reverse opioid effects. But medetomidine isn’t an opioid. Naloxone won’t reverse its sedative effects. That means someone can stop breathing from fentanyl, get Narcan, and still be severely sedated from medetomidine.

“Public health professionals can use syndromic surveillance to detect medetomidine-related intoxication or withdrawal signs and symptoms. Public health and public safety agencies and clinicians should collaborate to monitor the local drug supply and share timely information to align clinical and public health actions.” — CDC Health Advisory, April 2, 2026

Why This Matters for Families in Columbus, Cleveland, and Beyond

We all know someone affected by addiction. Maybe it’s a son, a daughter, a parent, a coworker. The drug supply is a moving target. Just as we got used to fentanyl being the main threat, now there’s a new twist. Medetomidine isn’t just making overdoses more likely—it’s making withdrawal more dangerous. And withdrawal is often what drives people back to using.

In our experience at Recovery Institute of Ohio, we’ve seen patients who were afraid to seek help because they didn’t know what they were withdrawing from. The severe withdrawal syndrome from medetomidine can be so intense that people need medical detox just to stabilize. That’s why we offer medically supervised detox and ongoing treatment tailored to the evolving drug landscape.

“Stopping medetomidine following regular use may lead to severe withdrawal, similar to clonidine withdrawal, with symptoms including hypertension, anxiety, nausea, vomiting, and fluctuating alertness, that can require emergency or intensive care.” — CDC Health Advisory

What This Means for Ohio’s Recovery Community

Ohio has been a leader in the fight against opioid addiction. Our state has expanded drug courts, launched mobile treatment units, and secured millions in federal funding. But medetomidine threatens to undo some of that progress. People who have been stable in recovery could relapse if they encounter this drug unknowingly. And for those still using, the risk of a fatal overdose just went up.

We also need to talk about frontline workers. Paramedics, ER staff, addiction counselors—they’re facing a new challenge. As we covered in Burnout Among Frontline Workers in Ohio: Secondary Trauma, Fatigue, and What’s Working, the emotional toll is real. Now they have to learn to recognize medetomidine’s effects and manage a withdrawal syndrome that can look like a medical emergency.

In Cincinnati, where we’ve worked closely with community partners through Targeted Interventions in Cincinnati: Reducing Overdoses in High-Risk Areas, we’re already adapting our approach. We’re training staff on the signs of medetomidine exposure and incorporating strategies to manage its unique withdrawal symptoms.

How to Protect Yourself and Your Loved Ones

So what can you do? First, know the signs of an overdose: slow or stopped breathing, blue lips or fingertips, unresponsiveness, pinpoint pupils. If you suspect an overdose, call 911 immediately and administer naloxone if you have it. Even though naloxone won’t reverse medetomidine, it can reverse the fentanyl part—and that might save a life.

Second, if you or someone you know is using, consider harm reduction strategies: don’t use alone, start with a small test dose, and have Narcan on hand. Fentanyl test strips can detect fentanyl, but they won’t detect medetomidine. The safest option is to seek treatment.

At Recovery Institute of Ohio, we provide comprehensive addiction treatment that addresses not just the substance, but the whole person. We offer medical detox, residential treatment, outpatient programs, and medication-assisted treatment (MAT). Our team understands the evolving drug supply and is ready to help you navigate it.

Recovery Is Possible—Even with a Changing Drug Supply

It’s easy to feel discouraged when the drug supply keeps shifting. But here’s the truth: treatment works. People recover every day, even from the most complicated polysubstance use. Medetomidine is a new challenge, but not an insurmountable one.

If you or someone you love is struggling with addiction in Ohio, know that you’re not alone. Recovery Institute of Ohio is here to help. Whether you’re in Columbus, Cleveland, Cincinnati, Dayton, Akron, or anywhere in between, we have programs designed to meet you where you are.

Don’t wait for an overdose to force a change. Call us today at (888) 705-0886 or visit our website to learn more. The path to recovery starts with a single step—and we’re here to walk it with you.

Federal funding for fentanyl test strips in Ohio has officially ended, leaving public health agencies scrambling to fill the gap. As of June 2026, the Ohio Department of Health has seen its supplies of these life-saving test strips dwindle, according to reporting from WOSU Public Media. This comes at a critical moment — overdose deaths have fallen nearly 50% since 2023, per Stateline, but the drug supply is becoming more dangerous with the emergence of new adulterants like medetomidine.

What Happened to the Funding?

The Trump administration prohibited the use of federal funds for fentanyl test strips, reversing a harm reduction tool that had been widely adopted. The Ohio Department of Health, which distributed test strips through local health departments and community organizations, is now warning that its stock is running low. Without new funding, these strips — which allow people to check if their drugs contain fentanyl — may soon be unavailable.

Here’s the thing: fentanyl test strips aren’t just a personal safety tool. They’re a public health intervention. By letting someone know their cocaine or heroin is laced with fentanyl, they can adjust their dose, use with a buddy, or seek help. In our experience at Recovery Institute of Ohio, we’ve seen how these small strips can be a gateway to conversations about treatment.

Ohio’s Overdose Decline: A Silver Lining?

Despite these funding cuts, there is some good news. A Stateline report from March 2026 shows that opioid overdose deaths across the U.S. have dropped by nearly 50% since 2023. Ohio has mirrored this trend, thanks in part to expanded access to naloxone and increased funding for treatment programs. As we discussed in our article on Ohio Secures $100 Million in Federal SOS Funding to Fight Substance Use, state and federal investments are making a difference.

But this progress is fragile. Federal funding cuts to test strips could reverse these gains. Dr. Mark Hurst, former medical director of the Ohio Department of Mental Health and Addiction Services, has noted that “harm reduction tools like test strips are essential to maintaining the momentum we’ve built.”

The New Threat: Medetomidine in the Drug Supply

Just as we’re losing one harm reduction tool, a new danger is emerging. According to a CDC Health Alert Network advisory from April 2026, the veterinary sedative medetomidine — often called “rhino tranq” — is increasingly being found in the illegal fentanyl supply. Medetomidine can cause profound sedation, bradycardia, and a severe withdrawal syndrome that may require intensive care.

“Medetomidine can cause profound sedation, bradycardia, and hypotension. Stopping medetomidine following regular use may lead to severe withdrawal, similar to clonidine withdrawal, with symptoms including hypertension, anxiety, nausea, vomiting, and fluctuating alertness.” — CDC Health Alert Network

Medetomidine is not detected by standard fentanyl test strips, which means even if someone tests their drugs, they may not know this sedative is present. That’s why we need broader drug checking technologies, such as mass spectrometry — but they’re more expensive and less accessible.

What This Means for Ohio Communities

For Ohioans in Columbus, Cleveland, Cincinnati, and beyond, this funding cut hits close to home. Many local harm reduction organizations rely on state supplies to distribute test strips at syringe service programs and community events. Without them, people who use drugs are left to navigate a more toxic supply blind.

A 2025 study in the Journal of Substance Use and Addiction Treatment found that fentanyl test strips reduced overdose risk by 30% among people who used them consistently. Losing access to these strips could lead to an uptick in fatalities, especially as new adulterants like medetomidine spread.

Meanwhile, Ohio has been a leader in harm reduction innovation. The state has expanded mobile treatment units and drug courts, as we explored in our coverage of Ohio Supreme Court decisions affecting opioid litigation. But without federal support for test strips, these efforts become harder.

Alternatives: How to Stay Safe Without Federal Funding

So what can Ohioans do now? First, know that naloxone remains widely available and can reverse opioid overdoses. You can get it at most pharmacies without a prescription. Second, consider using drug checking services that go beyond fentanyl strips. Some community organizations offer mail-in testing for a broader range of substances.

Third, if you or someone you love is struggling, don’t wait. Treatment works. At Recovery Institute of Ohio, we offer comprehensive programs that address addiction as a chronic disease, not a moral failing. From medical detox to outpatient counseling, we’re here to help.

And let’s be clear: abstinence isn’t the only path. Harm reduction saves lives, and every life saved is a chance at recovery. We need to advocate for funding restoration at the federal level. In the meantime, reach out to your local health department or a harm reduction organization to find out what resources are still available.

Conclusion: Recovery Is Possible

The end of federal funding for fentanyl test strips in Ohio is a setback, but it’s not the end of the story. Overdose deaths have been cut in half — that’s real progress. We can’t let funding decisions undo that. Every person deserves the chance to get help, whether through a test strip, a naloxone kit, or a treatment bed.

If you’re in Ohio and need support, don’t hesitate. Call us at Recovery Institute of Ohio today. Our team is ready to listen, to help, and to walk this road with you. Recovery is possible — and it starts with reaching out.